References

Agrawal, A., F. J. Civantos, K. T. Brumund, D. B. Chepeha, N. C. Hall, W. R. Carroll, R. B. Smith, R. P. Zitsch, W. T. Lee, Y. Shnayder, D. M. Cognetti, K. T. Pitman, D. W. King, L. A. Christman, and S. Y. Lai. 2015. [^99mTc]Tilmanocept Accurately Detects Sentinel Lymph Nodes and Predicts Node Pathology Status in Patients with Oral Squamous Cell Carcinoma of the Head and Neck: Results of a Phase III Multi-institutional Trial. Annals of Surgical Oncology 22(11):3708-3715.

EU (European Union). 2008. Official Journal of the European Union. Regulation (EC) No. 1234/2008 of 24 November 2008 concerning the examination of variations to the terms of marketing authorisations for medicinal products for human use and veterinary medicinal products (OJ L 334, 12.12.2008, p. 7).

IAEA (International Atomic Energy Agency). 2008. Homogeneous Aqueous Solution Nuclear Reactors for the Production of Mo-99 and Other Short Lived Radioisotopes. IAEA-TECDOC-1601. Vienna, Austria: IAEA. Available at http://www-pub.iaea.org/MTCD/publications/PDF/te_1601_web.pdf.

IAEA. 2015. Feasibility of Producing Molybdenum-99 on a Small Scale Using Fission of Low Enriched Uranium or Neutron Activation of Natural Molybdenum. Technical Reports Series No. 478. Vienna, Austria: IAEA. Available at http://www-pub.iaea.org/MTCD/Publications/PDF/trs478web-32777845.pdf.

IAEA. 2017. Cyclotron Based Production of Technetium-99m. IAEA Radioisotopes and Radiopharmaceuticals Reports No. 2. Vienna, Austria: IAEA. Available at http://www-pub.iaea.org/books/IAEABooks/10990/Cyclotron-Based-Production-of-Technetium-99m.

IOM and NRC (Institute of Medicine and National Research Council). 2007. Advancing Nuclear Medicine Through Innovation. Washington, DC: The National Academies Press.

NASEM (National Academies of Sciences, Engineering, and Medicine). 2016. Molybdenum-99 for Medical Imaging. Washington, DC: The National Academies Press.

NRC (National Research Council). 2009. Medical Isotope Production Without Highly Enriched Uranium. Washington, DC: The National Academies Press.

OECD-NEA (Organisation for Economic Co-operation and Development’s Nuclear Energy Agency). 2010. The Supply of Medical Radioisotopes—An Economic Study of the Molybdenum- 99 Supply Chain. NEA No. 6967. Paris: OECD. Available at https://www.oecd-nea.org/med-radio/reports/MO-99.pdf.

OECD-NEA. 2011. The Supply of Medical Radioisotopes: The Path to Reliability. NEA No. 6985. Paris: Organisation for Economic Co-operation and Development. Available at https://www.oecd-nea.org/med-radio/reports/med-radio-reliability.pdf.

OECD-NEA. 2012a. A Supply and Demand Update of the Molybdenum-99 Market. Paris: Organisation for Economic Co-operation and Development. Available at https://www.oecd-nea.org/med-radio/docs/2012-supply-demand-update-molybdenum-99-market.pdf.

OECD-NEA. 2012b. Guidance Document: Full-Cost Recovery for Molybdenum-99 Irradiation Services—Methodology and Implementation. Nuclear Development NEA/SEN/HLGMR(2012)9. Paris: Organisation for Economic Co-operation and Development. Available at http://www.oecd-nea.org/med-radio/guidance/docs/full-cost-recovery-molybdenum-99-irradiation.pdf.

OECD-NEA. 2013. The Supply of Medical Radioisotopes—Implementation of the HLG-MR Policy Approach: Results from a Self-Assessment by the Global ⁹⁹Mo/^99mTc Supply Chain. Nuclear Development NEA/SEN/HLGMR(2013)4. Paris: Organisation for Economic Co-operation and Development. Available at https://www.oecd-nea.org/ndd/reports/2013/implementation_hlg-mr_policy.pdf.

OECD-NEA. 2014a. The Supply of Medical Radioisotopes—Medical Isotope Supply in the Future: Production Capacity and Demand Forecast for the ⁹⁹Mo/^99mTc Market, 2015-2020. NEA/SEN/HLGMR(2014)2. Paris: Organisation for Economic Co-operation and Development. Available at http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=NEA/SEN/HLGMR(2014)2&docLanguage=En.

OECD-NEA. 2014b. The Supply of Medical Radioisotopes—Results from the Second Self-Assessment of the Global ⁹⁹Mo/^99mTc Supply Chain. NEA/SEN/HLGMR(2014)4. Paris: Organisation for Economic Co-operation and Development. Available at https://www.oecd-nea.org/cen/docs/2014/sen-hlgmr2014-4.pdf.

OECD-NEA. 2015a. The Supply of Medical Radioisotopes—2015 Medical Isotope Supply Review: ⁹⁹Mo/^99mTc Market Demand and Production Capacity Projection 2015-2020. NEA/SEN/HLGMR(2015)5. Paris: Organisation for Economic Co-operation and Development. Available at http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=NEA/SEN/HLGMR(2015)5&docLanguage=En.

OECD-NEA. 2015b. Joint Declaration on the Security of Supply of Medical Radioisotopes. Available at https://www.oecd-nea.org/med-radio/jointdeclaration.html. Accessed October 5, 2017.

OECD-NEA. 2016. The Supply of Medical Radioisotopes—2016 Medical Isotope Supply Review: ⁹⁹Mo/^99mTc Market Demand and Production Capacity Projection 2016-2021. NEA/SEN/HLGMR(2016)2. Available at https://www.oecd-nea.org/cen/docs/2016/sen-hlgmr2016-2.pdf.

OECD-NEA. 2017. The Supply of Medical Radioisotopes—2017 Medical Isotope Supply Review: ⁹⁹Mo/^99mTc Market Demand and Production Capacity Projection 2017-2022. NEA/SEN/HLGMR(2017)2. Available at https://www.oecd-nea.org/cen/docs/2017/sen-hlgmr2017-2.pdf.

Ryu, H. J., C. K. Kim, M. Sim, J. M. Park, and J. H. Lee. 2013. Development of high-density U/Al dispersion plates for Mo-99 production using atomized uranium power. Nuclear Engineering and Technology 45(7):979-986.